| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/03/2001 | US6211246 Rapidly absorbed liquid compositions |
| 04/03/2001 | US6211245 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 04/03/2001 | US6211244 Aromatic amines for complexing calcium |
| 04/03/2001 | US6211243 Methods for treating cold sores with anti-infective compositions |
| 04/03/2001 | US6211242 Benzamide derivatives as vasopressin antagonists |
| 04/03/2001 | US6211239 Anticarcinogenic agents for treatment of leukemia |
| 04/03/2001 | US6211235 Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
| 04/03/2001 | US6211234 Substituted phenyl compounds |
| 04/03/2001 | US6211233 Prostaglandin pharmaceutical compositions |
| 04/03/2001 | US6211231 Stabilized vitamin C formulations |
| 04/03/2001 | US6211230 Antidotes for organophosphorous nerve agents by administering hu-211 |
| 04/03/2001 | US6211229 Administering doxepin, amitripyline, trimipramine, trazodone and mixtures for sleep aids |
| 04/03/2001 | US6211228 Compositions and methods for treating mast-cell mediated conditions |
| 04/03/2001 | US6211226 11-Aza prostaglandins for the treatment of glaucoma and ocular hypertension |
| 04/03/2001 | US6211225 Sleep disorders and circadian rhythm disorders |
| 04/03/2001 | US6211222 Substituted indazole derivatives and related compounds |
| 04/03/2001 | US6211221 Administering to females during menses |
| 04/03/2001 | US6211220 Method for treating neoplasia with amino or pyridylamino cyclobutene derivatives |
| 04/03/2001 | US6211217 Method for reducing pericardial fibrosis and adhesion formation |
| 04/03/2001 | US6211212 Drugs with amide and ester groups as enzyme inhibitors |
| 04/03/2001 | US6211211 Anxiolytic, anticonvulsant and antiepileptic agent |
| 04/03/2001 | US6211210 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use |
| 04/03/2001 | US6211209 Method of inhibiting connective tissue degradation |
| 04/03/2001 | US6211208 2-aminopyridines containing fused ring substituents |
| 04/03/2001 | US6211207 Pharmaceutical composition |
| 04/03/2001 | US6211206 Pharmaceutical composition |
| 04/03/2001 | US6211205 Pharmaceutical composition |
| 04/03/2001 | US6211203 Respiratory system disorders, antiinflammatory agents, enzyme inhibitors |
| 04/03/2001 | US6211201 Multivalent salts of pyridostigmine and related compounds |
| 04/03/2001 | US6211200 Administering zinc chelated imidazo(4,5-d)imidazole compounds as granulocyte colony stimulating factor agonists |
| 04/03/2001 | US6211197 Carboxylic acid or tetrazole derivates; analgesics, antipyretics, and antiinflammatory agents; side effect reduction |
| 04/03/2001 | US6211196 Benzyloxy-substituted, fused N-heterocycles, processes for their preparation, and their use as bradykinin receptor antagonists |
| 04/03/2001 | US6211195 Nervous system, psychological and glandular disorders |
| 04/03/2001 | US6211194 Solution containing nicotine |
| 04/03/2001 | US6211193 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives; antitumor and anticarcinogenic agents |
| 04/03/2001 | US6211192 Alkynyl-substituted camptothecins and process for their preparation |
| 04/03/2001 | US6211189 Nitric oxide synthase inhibitors; antiinflammatory agents, analgesics |
| 04/03/2001 | US6211188 Treatment of skin disorders |
| 04/03/2001 | US6211187 Post-traumatic stress; antidepressants, anxiolytic agents |
| 04/03/2001 | US6211186 Polyoxyalkylene glycol modified with n-heterocycle derivative with amidine or guanidine group; diaper rash, obesity, acne, periodontal disease, contraceptives; protease and lipase inhibitors |
| 04/03/2001 | US6211185 Concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution, and a suspending agent |
| 04/03/2001 | US6211184 Tetrahydro-pyrazine or pyrimidine derivatives; vitronectin receptor antagonist; osteoporosis; antiinflammatory, antitumor agents; angiogenesis and restenosis inhibitors |
| 04/03/2001 | US6211183 Selective factor Xa inhibitors |
| 04/03/2001 | US6211182 Histamine h3-antagonists; antiinflammatory agents, antiallergens, antiasthmatics; nervous system, psychological, sleep, and gastrointestinal disorders |
| 04/03/2001 | US6211181 1-Benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonists |
| 04/03/2001 | US6211179 Treating sexual disorders, impotency, and menopause; administering purine derivative; nitric oxide synthase substrates |
| 04/03/2001 | US6211177 Side effect reduction |
| 04/03/2001 | US6211175 Cardiac diseases improving method |
| 04/03/2001 | US6211174 Osteoporosis; milk production and carcass quality in livestock; short stature; metabolic disorders |
| 04/03/2001 | US6211173 Use of 2,3,4,5-tetrahydro-1H-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders |
| 04/03/2001 | US6211171 Administering tricyclic amitriptyline and desipramine to treat neuropathic pain |
| 04/03/2001 | US6211170 Azetidinone derivatives for the treatment of HCMV infections |
| 04/03/2001 | US6211169 Stable calcitriol solution for packaging into vials |
| 04/03/2001 | US6211168 Methods for preparation and use of 1α,24 (S)-dihydroxy vitamin D2 |
| 04/03/2001 | US6211167 Arylsulfonanilide phosphates |
| 04/03/2001 | US6211166 Coadministered with a 5-fluorouracil derivative; anticarcinogenic agents |
| 04/03/2001 | US6211165 Gene expression; binary conjugates |
| 04/03/2001 | US6211164 Sensitization of tumor cells |
| 04/03/2001 | US6211162 Pulmonary delivery of protonated/acidified nucleic acids |
| 04/03/2001 | US6211155 Stimulating immune system with peptides conjugated with mono-or dicarboxylic acid; |
| 04/03/2001 | US6211147 Method of promoting angiogenesis using relaxin |
| 04/03/2001 | US6210974 Compositions and methods for promoting nerve regeneration |
| 04/03/2001 | US6210950 Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors |
| 04/03/2001 | US6210944 Phosphoribosyl transferase from Staphylococcus aureus |
| 04/03/2001 | US6210918 Detecting level of nitric oxide, arginine or citrulline, or activity or expression of nitric oxide synthase, or conversion of nitric oxide to nitrate and nitrite in sample, and comparing to non-laboring pregnant female |
| 04/03/2001 | US6210917 By treating methylthioadenosine phosphorylase deficient cells with adenine synthesis inhibitor to deplete the target cells of adenosine 5'-triphosphate |
| 04/03/2001 | US6210717 System for transporting genes into eukaryotic cells; used for transforming targeted host cell |
| 04/03/2001 | US6210708 Cationic virosomes as transfer system for genetic material |
| 04/03/2001 | US6210707 Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| 04/03/2001 | US6210706 S (+) Desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions |
| 04/03/2001 | US6210705 Flexible, finite system wherein the methylphenidate is present in an amount sufficient to achieve substantially zero order kinetics for delivery to the skin or mucosa of a patient in need thereof over a period of time at least 10 hours. |
| 04/03/2001 | US6210687 Fat emulsion containing xanthine derivative |
| 04/03/2001 | US6210686 Yeast-derived glucomannan fiber; folic acid; vitamin b6; vitamin b12; vitamin e |
| 04/03/2001 | US6210685 Acellular whooping cough vaccines. |
| 04/03/2001 | US6210680 Administration to a patient in need thereof an effective amount of an isoquinoline alkaloid. |
| 04/03/2001 | US6210664 Method for gene transfer to the central nervous system |
| 04/03/2001 | US6210662 Fusion protein having prostatic acid phosphatase (pap) as an n-terminal moiety and gm-csf as a c-terminal moiety, and wherein said cells are effective to activate t-cells to produce a multivalent cytotoxic cellular immune response |
| 04/03/2001 | US6210657 Use of isoindolinone derivatives as stabilizers for organic materials |
| 04/03/2001 | US6210654 Jak kinases and regulation of cytokine signal transduction |
| 04/03/2001 | US6210394 Surgical irrigation solution and method for inhibition of pain and inflammation |
| 04/03/2001 | US6210343 Use of misoprostol or/and misoprostol acid for diagnosis of vascular damage in a subject with erectile dysfunction |
| 04/03/2001 | CA2211120C Lineage-directed induction of human mesenchymal stem cell differentiation |
| 04/03/2001 | CA2200169C Triazole antifungal agents |
| 04/03/2001 | CA2188147C Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 04/03/2001 | CA2102772C Azetidinone compound and process for preparation thereof |
| 04/03/2001 | CA2074186C Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| 04/03/2001 | CA2034811C Selective processes for fosinopril polymorphs |
| 04/03/2001 | CA2028287C Benzocycloalkylaminopyridinamines and related compounds, a process and intermediates for their preparation and their use as medicaments |
| 04/03/2001 | CA2027831C L-sugar laxatives |
| 04/03/2001 | CA2023951C N-hydroxy-dibenz¢b,e!oxepin -alkylamines and -alkanoic acid amides, related heterocyclic analogues, a process for their preparation and their use as medicaments |
| 04/03/2001 | CA2022486C 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-ones, a process for their preparation and their use as medicaments |
| 04/01/2001 | CA2321593A1 .alpha.-sulfonylamino hydroxamic acid inhibitors of matrix metalloproteinases for the treatment of peripheral or central nervous system disorders |
| 04/01/2001 | CA2321324A1 Quinolin-4yl derivatives |
| 04/01/2001 | CA2284345A1 Composition for the treatment of oral lesions |
| 03/30/2001 | WO2003044525A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease |
| 03/30/2001 | WO2003042411A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease |
| 03/30/2001 | CA2385808A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease |
| 03/30/2001 | CA2380624A1 Mutation of mec-1 related genes in the treatment of disease |
| 03/30/2001 | CA2321379A1 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 03/30/2001 | CA2321378A1 Combination effective for the treatment of impotence |